IRCT20240515061805N1
Recruiting
Phase 2
Comparison of dexmedetomidine versus propofol intravenous sedation for electrochemotherapy of breast cancer skin lesion: double-blinded clinical trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 36
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Symptomatic metastatic skin lesions (like bleeding, exudation, smell or ulceration)
- •development of skin metastases, in which the symptoms mentioned can be expected
- •Patients who receive systemic treatment and have a good effect on their primary cancer, but their skin lesions do not respond to these treatments or are progressing
- •patients preferring electrochemistry
- •multiple skin lesions or a lesion larger than 1 cm
- •ASA group II, I, III
- •patients between 18 and 60 years old
Exclusion Criteria
- •Pregnancy and breastfeeding
- •Allergy to any of the drugs used in the study
- •hypertension
- •impaired liver and kidney function
- •Hereditary heart diseases
- •ischemic heart disease,
- •using beta blockers and sedative drugs
- •refusing to sign an informed consent form
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Comparative effect of propofol and dexmedetomidine on fertility rate in patients candidate for IVFinfertility.N97. 9IRCT20190121042444N2Shahid Beheshti University of Medical Sciences78
Recruiting
Not Applicable
Comparison effect of propofol and Dexmedetomidine in hemodynamic ?response in emergency intubatioIRCT2016102520258N14Vice chancellor for research, Arak University of Medical Sciences114
Not yet recruiting
Not Applicable
Comparison of the effect of propofol vs dexmedetomidine sedation on NIHSS score (National institute of health stroke scale) and SSEP(somatosensory evoked potential ) in patients for supratentorial tumors.Health Condition 1: C713- Malignant neoplasm of parietal lobeHealth Condition 2: C713- Malignant neoplasm of parietal lobeHealth Condition 3: C712- Malignant neoplasm of temporal lobeCTRI/2022/02/040164Sree Chitra Tirunal institute of Medical sciences and technology
Completed
Phase 2
Comparison of two medications in reducing blood pressure and bleeding in sinus surgeryChronic sinusitis.Chronic sinusitisIRCT2015101814056N5Arak University of Medical Sciences, Vice Chancellor for Research100
Not yet recruiting
Phase 1
Comparison of Dexmedetomidine versus Midazolam withPropofol for Proseal LMA InsertioHealth Condition 1: 4- Measurement and MonitoringCTRI/2024/03/063738ACS Medical College and Hospital